- Cancer PHGKB -
Last Posted: Feb 25, 2020
- Should polygenic risk scores be used in risk-stratified colorectal cancer screening?
WD Dotson et al, CDC Blog Post, February 24, 2020
- Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer.
Yarmolinsky James et al. JAMA 2020 Feb (7) 646-655
- Disparities in BRCA counseling across providers in a diverse population of young breast cancer survivors.
Reid Sonya et al. Genetics in medicine : official journal of the American College of Medical Genetics 2020 Feb
- The pan-cancer landscape of prognostic germline variants in 10,582 patients.
Chatrath Ajay et al. Genome medicine 2020 Feb (1) 15
- Management of Male Breast Cancer: ASCO Guideline.
Hassett Michael J et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 Feb JCO1903120
- Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer.
Mills Justin et al. American family physician 2020 Feb 101(4) 239-240
- Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Recommendation Statement.
et al. American family physician 2020 Feb 101(4) 233-238
- [Clinical Cancer Genetics: A guide for the pathologist].
Basset Noémie et al. Annales de pathologie 2020 Feb
- [Hereditary breast and ovarian cancer syndrome: Diagnosis and therapeutic implications].
Koual Meriem et al. Annales de pathologie 2020 Feb
- A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results.
Cortesi Laura et al. Cancer medicine 2020 Feb
- Application of Machine Learning in Developing a Novelty Five-Pseudogene Signature to Predict Prognosis of Head and Neck Squamous Cell Carcinoma: A New Aspect of "Junk Genes" in Biomedical Practice.
Xing Lu et al. DNA and cell biology 2020 Feb
- Clinical significance of EGFR mutation types in lung adenocarcinoma: A multi-centre Korean study.
Yoon Hee-Young et al. PloS one 2020 15(2) e0228925
- Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages.
Guibert Nicolas et al. European respiratory review : an official journal of the European Respiratory Society 2020 Mar 29(155)
- Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.
Shen Chengquan et al. International immunopharmacology 2020 Feb 81106274
- Evaluation of current genetic testing reports in German-speaking countries with regard to secondary use and future electronic implementation.
Radke Teja Falk et al. European journal of human genetics : EJHG 2020 Feb
- CDC Information (108)
- NIH Information (236)
- CDC Genomics Publications (137)
- Human Genome Epidemiologic Studies (40820)
- GWAS Studies (597)
- Human Genomics Translation/Implementation Studies (5030)
- Genomic Tests Evidence Synthesis (537)
- Genomic Tests Guidelines (349)
- Tier-Classified Guidelines (181)
- Non-Genomics Precision Health (454)
- Pathogen Advanced Molecular Detection (173)
- State Public Health Genomics Programs (192)
- Reviews/Commentaries (3886)
- Tools/Methods (154)
- Ethical/Legal and Social Issues (ELSI) (154)
Quick Links to Other Resources
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.